Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Biuti Sikrets | Beauty & Personal Care | 16.3% | 63rd pct | 35 |
| New Vizhen Kosmetiks | Beauty & Personal Care | 10.9% | 49th pct | 35 |
| Parpiumi | Beauty & Personal Care | 9.0% | 40th pct | 35 |
| Parmasi + | Beauty & Personal Care | 6.0% | 29th pct | 35 |
| Kriala + | Beauty & Personal Care | 1.4% | 11th pct | 35 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
| Ratio — FY 2024 | Biuti Sikrets | Kriala + | New Vizhen Kosmetiks | Parpiumi | Parmasi + |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 41.8% | 15.0% | 45.3% | 67.5% | 52.6% |
| EBITDA Margin | 16.3% | 1.4% | 10.9% | 9.0% | 6.0% |
| EBITDAR | 967 | 159 | 428 | 339 | 229 |
| EBITDAR Margin | 20.5% | 3.5% | 12.8% | 10.6% | 7.3% |
| EBIT Margin | 16.1% | 0.8% | 10.1% | 8.8% | 4.5% |
| Net Profit Margin | 13.3% | -0.1% | 10.1% | 7.7% | 3.7% |
| Operating Expense % of Sales | 25.4% | 13.6% | 34.4% | 58.6% | 46.6% |
| Returns | |||||
| Return on Assets (ROA) | 21.9% | -0.5% | 14.2% | 11.9% | 8.9% |
| Return on Equity (ROE) | 25.0% | -8.5% | 14.9% | 16.7% | 13.9% |
| ROIC [EBIT / Invested Capital] | 33.5% | 6.3% | 19.4% | 15.0% | 11.8% |
| Leverage & debt balances | |||||
| Debt-to-Assets | 1.6% | 86.8% | 0.0% | 27.6% | 34.3% |
| Debt-to-Equity | 0.02x | 15.76x | 0.00x | 0.39x | 0.54x |
| Debt-to-EBITDA | 0.06x | 8.52x | 0.00x | 2.01x | 2.34x |
| Equity-to-Assets | 87.7% | 5.5% | 95.4% | 70.9% | 64.1% |
| Net Debt | -242 | 543 | -537 | 389 | 383 |
| Cash & Equivalents | 287 | 19 | 538 | 185 | 58 |
| Total Debt | 45 | 562 | 1 | 574 | 441 |
| Liquidity & working capital | |||||
| Current Ratio | 15.96x | 1.73x | 20.25x | 9.87x | 2.04x |
| Quick Ratio | 15.96x | 1.73x | 20.25x | 9.87x | 2.04x |
| Cash Ratio | 1.61x | 0.03x | 4.89x | 9.13x | 0.13x |
| Total Current Assets | 2,846 | 1,060 | 2,226 | 201 | 943 |
| Total Current Liabilities | 178 | 611 | 110 | 20 | 462 |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Trade Receivables | 1,240 | 89 | 962 | 1,653 | 72 |
| Trade Payables | 133 | N/A | 84 | 20 | N/A |
| Net Working Capital | 2,668 | 449 | 2,116 | 180 | 481 |
| Net Working Capital % of Revenue | 56.6% | 9.9% | 63.2% | 5.6% | 15.3% |
| Trade Working Capital | 1,107 | 89 | 878 | 1,632 | 72 |
| Trade Working Capital % of Revenue | 23.5% | 2.0% | 26.2% | 51.1% | 2.3% |
| Change in Trade Working Capital | N/A | N/A | N/A | N/A | N/A |
| Turnover & efficiency | |||||
| Inventory Turnover | N/A | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A | N/A | N/A |
| Receivables Turnover | 3.80x | 50.98x | 3.48x | 1.93x | 43.58x |
| Days Sales Outstanding (DSO) | 96.0 | 7.2 | 104.8 | 188.9 | 8.4 |
| Payables Turnover | 20.62x | N/A | 21.80x | 51.04x | N/A |
| Days Payable Outstanding (DPO) | 17.7 | N/A | 16.7 | 7.2 | N/A |
| Cash Conversion Cycle | 78.3 days | 7.2 days | 88.1 days | 181.8 days | 8.4 days |
| Asset Turnover | 1.65x | 7.03x | 1.40x | 1.53x | 2.44x |
| Cash flow & dividends | |||||
| Operating Cash Flow | N/A | N/A | 448 | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | N/A | N/A | 405 | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | 122.9% | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A |